Literature DB >> 19818059

Budget impact analysis of thrombolysis for stroke in Spain: a discrete event simulation model.

Javier Mar1, Arantzazu Arrospide, Mercè Comas.   

Abstract

OBJECTIVE: Thrombolysis within the first 3 hours after the onset of symptoms of a stroke has been shown to be a cost-effective treatment because treated patients are 30% more likely than nontreated patients to have no residual disability. The objective of this study was to calculate by means of a discrete event simulation model the budget impact of thrombolysis in Spain.
METHODS: The budget impact analysis was based on stroke incidence rates and the estimation of the prevalence of stroke-related disability in Spain and its translation to hospital and social costs. A discrete event simulation model was constructed to represent the flow of patients with stroke in Spain.
RESULTS: If 10% of patients with stroke from 2000 to 2015 would receive thrombolytic treatment, the prevalence of dependent patients in 2015 would decrease from 149,953 to 145,922. For the first 6 years, the cost of intervention would surpass the savings. Nevertheless, the number of cases in which patient dependency was avoided would steadily increase, and after 2006 the cost savings would be greater, with a widening difference between the cost of intervention and the cost of nonintervention, until 2015.
CONCLUSION: The impact of thrombolysis on society's health and social budget indicates a net benefit after 6 years, and the improvement in health grows continuously. The validation of the model demonstrates the adequacy of the discrete event simulation approach in representing the epidemiology of stroke to calculate the budget impact.

Entities:  

Mesh:

Year:  2009        PMID: 19818059     DOI: 10.1111/j.1524-4733.2009.00655.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  11 in total

1.  Regional variability in changes in the incidence of hip fracture in the Spanish population (2000-2012).

Authors:  I Etxebarria-Foronda; A Arrospide; M Soto-Gordoa; J R Caeiro; L C Abecia; J Mar
Journal:  Osteoporos Int       Date:  2015-01-09       Impact factor: 4.507

2.  Cost-utility analysis of gastric bypass for severely obese patients in Spain.

Authors:  Iván Castilla; Javier Mar; Cristina Valcárcel-Nazco; Arantzazu Arrospide; Juan M Ramos-Goñi
Journal:  Obes Surg       Date:  2014-12       Impact factor: 4.129

3.  Validating a Budget Impact Model Using Payer Insight and Claims Data: A Framework and Case Study.

Authors:  Anna Hung; Julia F Slejko; Amy Lugo; Fadia Shaya; Stuart T Haines; C Daniel Mullins
Journal:  J Manag Care Spec Pharm       Date:  2019-08

4.  Barriers of thrombolysis therapy in developing countries.

Authors:  Kavian Ghandehari
Journal:  Stroke Res Treat       Date:  2011-03-17

5.  The impact of acquired brain damage in terms of epidemiology, economics and loss in quality of life.

Authors:  Javier Mar; Arantzazu Arrospide; José María Begiristain; Isabel Larrañaga; Elena Elosegui; Juan Oliva-Moreno
Journal:  BMC Neurol       Date:  2011-04-18       Impact factor: 2.474

6.  Fitting the epidemiology and neuropathology of the early stages of Alzheimer's disease to prevent dementia.

Authors:  Javier Mar; Myriam Soto-Gordoa; Arantzazu Arrospide; Fermín Moreno-Izco; Pablo Martínez-Lage
Journal:  Alzheimers Res Ther       Date:  2015-01-15       Impact factor: 6.982

7.  "Budget impact analyses": a practical policy making tool for drug reimbursement decisions.

Authors:  Hamid Reza Jamshidi; Naghmeh Foroutan; Jamshid Salamzadeh
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

8.  Economic Evaluation of an Integrated Health and Social Care Program for Heart Failure Through 2 Different Modeling Techniques.

Authors:  Igor Larrañaga; Panos Stafylas; Ane Fullaondo; Gian Matteo Apuzzo; Javier Mar
Journal:  Health Serv Res Manag Epidemiol       Date:  2018-12-03

9.  Real-World Cost-Effectiveness of Late Time Window Thrombectomy for Patients With Ischemic Stroke.

Authors:  Lan Gao; Andrew Bivard; Mark Parsons; Neil J Spratt; Christopher Levi; Kenneth Butcher; Timothy Kleinig; Bernard Yan; Qiang Dong; Xin Cheng; Min Lou; Congguo Yin; Chushuang Chen; Peng Wang; Longting Lin; Philip Choi; Ferdinand Miteff; Marj Moodie
Journal:  Front Neurol       Date:  2021-12-14       Impact factor: 4.003

10.  Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model.

Authors:  Mercè Comas; Arantzazu Arrospide; Javier Mar; Maria Sala; Ester Vilaprinyó; Cristina Hernández; Francesc Cots; Juan Martínez; Xavier Castells
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.